Human Pancreas Analysis Program-T2D
人类胰腺分析程序-T2D
基本信息
- 批准号:10569497
- 负责人:
- 金额:$ 110万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-22 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAddressAlberta provinceAlpha CellArchitectureAtlasesBeta CellBiological AssayBiologyBody Weight decreasedCapitalCellular biologyCharacteristicsClinicalCollaborationsColorCommunitiesCoupledDataDatabasesDevelopmentDiabetes MellitusDietDiseaseFloridaFosteringFunctional disorderGenetic RiskGlucagonGoalsHepaticHeterogeneityHumanHuman BioMolecular Atlas ProgramHuman GeneticsHyperglycemiaImpairmentIndividualInfrastructureInsulinInsulin ResistanceInsulin-Dependent Diabetes MellitusIslets of LangerhansKnowledgeLeadershipLifeMedicineMolecularMolecular AnalysisMolecular BiologyNeonatalNon-Insulin-Dependent Diabetes MellitusOralOrganOrgan DonationsOrgan DonorOutputPancreasPathogenesisPathologyPharmaceutical PreparationsPhenotypePhysiologyPositioning AttributePrediabetes syndromeProcessProductivityRecording of previous eventsResearchResearch PersonnelResolutionResourcesRoleScientistSiteTechniquesTechnologyTissuesbariatric surgerybiomarker developmentclinical developmentclinical phenotypecollaborative approachdata integrationdesignexperienceextracellularglucose productionimprovedinsulin secretioninterdisciplinary approachinterestisletmultimodalitynew technologynon-diabeticpreventprogramsresponsetargeted treatmenttherapeutic developmenttherapy design
项目摘要
Type 2 diabetes mellitus (T2D) results from insulin resistance, increased hepatic glucose
production, and impaired islet function which is likely a key determinant of whether T2D
develops. However, the molecular mechanisms responsible for islet dysfunction are
incompletely defined and largely unknown. To address these challenges, we submit this
application in response to FOA-DK-18-016, Human Pancreas Analysis Program for Type-2
Diabetes (HPAP-T2D). Our collaborative and interdisciplinary team will interrogate T2D human
pancreatic tissue and islets from clinically phenotyped or “staged” donors using the range of
experimental approaches outlined in the RFA and new experimental techniques. Our team will:
(1) Collect and process the pancreas and islets from individuals with; (a) prediabetes, (b) T2D
diabetes treated with only diet and/or oral medications, (c) T2D diabetes treated with insulin,
and (d) from normal controls, and determine their genetic risk for T2D; (2) Use the broad range
of molecular techniques requested by the RFA and integration with new and emerging
experimental approaches to comprehensively phenotype the pancreatic islets isolated from
designated donor groups to understand molecular changes in T2D; (3) Use state-of-the-art
approaches coupled with new cutting-edge multiplexing technology, to comprehensively analyze
pancreatic tissue architecture in cellular and extracellular compartments from designated donor
groups; (4) Integrate data from these studies into the comprehensive, open-access, searchable
PANC-DB database, and help develop this resource to serve the community of scientists
interested in understanding human pancreatic and islet biology in T2D; (5) Create, enhance,
and leverage partnerships with complementary programs like HPAP-T1D, HIRN, IIDP, nPOD,
AMP-T2D, and QUOD. Our group of investigators has been collaborating extensively on studies
of the human pancreas and islets, including T2D pancreatic organs with associated clinical
information as called for in this RFA. We are committed to harmonization, integration, and co-
registration of data from the different approaches with the ultimate output of our efforts being a
comprehensive T2D profile available to all investigators interested in T2D through PANC-DB.
Thus, the successful formation of our proposed program should lead to improved understanding
of the T2D pathogenesis as well as the design of therapies capable of preventing and/or
reversing the disorder.
2型糖尿病(T2 D)是由胰岛素抵抗、肝葡萄糖升高
产生,以及胰岛功能受损,这可能是T2 D是否发生的关键决定因素
发展起来的然而,负责胰岛功能障碍的分子机制是
不完全定义和大部分未知。为了应对这些挑战,我们提出
响应FOA-DK-18-016,2型人胰腺分析程序的应用
糖尿病(HPAP-T2 D)。我们的合作和跨学科团队将询问T2 D人类
胰腺组织和胰岛从临床表型或“分期”供体使用的范围
RFA中概述的实验方法和新的实验技术。我们的团队将:
(1)收集和处理来自以下个体的胰腺和胰岛:(a)前驱糖尿病,(B)T2 D
仅用饮食和/或口服药物治疗的糖尿病,(c)用胰岛素治疗的T2 D糖尿病,
和(d)正常对照,并确定其T2 D的遗传风险;(2)使用广泛的
RFA所要求的分子技术,以及与新的和新兴的
实验方法,以全面表型胰岛分离自
指定供体组,以了解T2 D的分子变化;(3)使用最先进的
结合新的尖端多路复用技术,全面分析
来自指定供体的细胞和细胞外区室中的胰腺组织结构
(4)将这些研究的数据整合到全面的,开放获取的,可搜索的
PANC-DB数据库,并帮助开发此资源,为科学家社区服务
对了解T2 D中的人类胰腺和胰岛生物学感兴趣;(5)创建,增强,
并利用与HPAP-T1 D、HIRN、IIDP、nPOD等互补项目的合作关系,
AMP-T2 D和QUOD.我们的研究小组一直在广泛合作研究
人胰腺和胰岛,包括T2 D胰腺器官,
本RFA中要求的信息。我们致力于协调、整合和合作,
从不同的方法与我们的努力的最终输出数据登记是一个
通过PANC-DB向所有对T2 D感兴趣的研究者提供全面的T2 D特征。
因此,我们提出的方案的成功形成应导致更好的理解,
T2 D发病机制以及能够预防和/或
逆转紊乱
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK A. ATKINSON其他文献
MARK A. ATKINSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK A. ATKINSON', 18)}}的其他基金
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
人类1型糖尿病心血管并发症研究生物储存库和协调中心
- 批准号:
10879240 - 财政年份:2022
- 资助金额:
$ 110万 - 项目类别:
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
人类1型糖尿病心血管并发症研究生物储存库和协调中心
- 批准号:
10672443 - 财政年份:2022
- 资助金额:
$ 110万 - 项目类别:
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
人类1型糖尿病心血管并发症研究生物储存库和协调中心
- 批准号:
10512888 - 财政年份:2022
- 资助金额:
$ 110万 - 项目类别:
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
1 型糖尿病期间人类胰腺细胞组织、表型和功能的共同注册
- 批准号:
10343979 - 财政年份:2021
- 资助金额:
$ 110万 - 项目类别:
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
1 型糖尿病期间人类胰腺细胞组织、表型和功能的共同注册
- 批准号:
10673726 - 财政年份:2021
- 资助金额:
$ 110万 - 项目类别:
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
1 型糖尿病期间人类胰腺细胞组织、表型和功能的共同注册
- 批准号:
10490416 - 财政年份:2021
- 资助金额:
$ 110万 - 项目类别:
Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis
1型糖尿病发病机制中人胰腺形态和功能的区域和小叶异质性
- 批准号:
10400943 - 财政年份:2020
- 资助金额:
$ 110万 - 项目类别:
Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis
1型糖尿病发病机制中人胰腺形态和功能的区域和小叶异质性
- 批准号:
10617206 - 财政年份:2020
- 资助金额:
$ 110万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 110万 - 项目类别:
Research Grant